Cosmetic Use of Botulinum Toxin for Upper Face

Article Sidebar

PDF
Published: Nov 19, 2022
DOI: https://doi.org/10.47191/ijmscrs/v2-i11-33
Keywords:
..

Main Article Content

Yuri Jiménez Caprielova
General Surgery Department, Centro Médico Nacional del Noreste IMSS 25, Nuevo León, Mexico
Andrea minerva rodriguez moreno
General Surgery Department, Centro Médico Nacional del Noreste IMSS 25, Nuevo León, Mexico

Abstract

Botulinum toxin is an injectable neuromodulator derived from neurotoxins produced by the bacterium Clostridium botulinum, which causes botulism. The human face is made up of a complex network of muscles that work together to create facial expressions and perform essential functions. Clinicians who understand facial anatomy and the functional relationships between muscles in the face and neck can use botulinum toxin safely to selectively weaken specific muscles, resulting in favorable cosmetic results.

Article Details

How to Cite
Caprielova, Y. J. ., & rodriguez moreno, A. minerva . (2022). Cosmetic Use of Botulinum Toxin for Upper Face. International Journal of Medical Science and Clinical Research Studies, 2(11), 1318–1320. https://doi.org/10.47191/ijmscrs/v2-i11-33
Issue
Vol. 2 No. 11 (2022): Volume 02 Issue 11 November 2022
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. Phan, K., Younessi, S., Dubin, D., Lin, M. J., & Khorasani, H. (2022). Emerging off‐label esthetic uses of botulinum toxin in dermatology. Dermatologic Therapy, 35(1), e15205.

II. Tian, Y. I., Kanade, T., & Cohn, J. F. (2001). Recognizing action units for facial expression analysis. IEEE Transactions on pattern analysis and machine intelligence, 23(2), 97-115.

III. Klein, A. W. (2004). Contraindications and complications with the use of botulinum toxin. Clinics in dermatology, 22(1), 66-75.

IV. Carruthers, J., Fagien, S., & Matarasso, S. L. (2004). Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plastic and reconstructive surgery, 114(6), 1S-22S.

V. Setler, P. E. (2002). Therapeutic use of botulinum toxins: background and history. The Clinical journal of pain, 18(6), S119-S124.

VI. Fagien, S., Carruthers, A., & Carruthers, J. (2007). Expanded uses of BTX-A for facial aesthetic enhancement. Putterman's Cosmetic Oculoplastic Surgery E-Book.

VII. Charles Finn, J., Cox, S. E., & Earl, M. L. (2003). Social implications of hyperfunctional facial lines. Dermatologic surgery, 29(5), 450-455.

VIII. Jaspers, G. W. C., Pijpe, J., & Jansma, J. (2011). The use of botulinum toxin type A in cosmetic facial procedures. International journal of oral and maxillofacial surgery, 40(2), 127-133.

IX. Walker, T. J., & Dayan, S. H. (2014). Comparison and overview of currently available neurotoxins. The Journal of Clinical and Aesthetic Dermatology, 7(2), 31.

X. Morley, A. M., Taban, M., Malhotra, R., & Goldberg, R. A. (2009). Use of hyaluronic acid gel for upper eyelid filling and contouring. Ophthalmic Plastic & Reconstructive Surgery, 25(6), 440-444.

XI. Nestor, M. S., Arnold, D., & Fischer, D. (2020). The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: Key Clinical Postulates II. Journal of cosmetic dermatology, 19(11), 2785-2804.

XII. Matarasso, S. L. (1998). Complications of botulinum A exotoxin for hyperfunctional lines. Dermatologic surgery, 24(11), 1249-1254.

XIII. Garcia, R. M., Hadlock, T. A., Klebuc, M. J., Simpson, R. L., Zenn, M. R., & Marcus, J. R. (2015). Contemporary solutions for the treatment of facial nerve paralysis. Plastic and reconstructive surgery, 135(6), 1025e-1046e.

XIV. Lorenc, Z. P., Smith, S., Nestor, M., Nelson, D., & Moradi, A. (2013). Understanding the functional anatomy of the frontalis and glabellar complex for optimal aesthetic botulinum toxin type A therapy. Aesthetic plastic surgery, 37(5), 975-983.

XV. Evinger, C., Manning, K. A., & Sibony, P. A. (1991). Eyelid movements. Mechanisms and normal data. Investigative ophthalmology & visual science, 32(2), 387-400.

XVI. Michaud, T., Gassia, V., & Belhaouari, L. (2015). Facial dynamics and emotional expressions in facial aging treatments. Journal of cosmetic dermatology, 14(1), 9-21.

XVII. Cartee, T. V., & Monheit, G. D. (2011). An overview of botulinum toxins: past, present, and future. Clinics in plastic surgery, 38(3), 409-426.

XVIII. Lehrer, M. S., & Benedetto, A. V. (2005). Botulinum toxin–an update on its use in facial rejuvenation. Journal of Cosmetic Dermatology, 4(4), 285-297.

XIX. Wollina, U., & Konrad, H. (2005). Managing adverse events associated with botulinum toxin type A. American journal of clinical dermatology, 6(3), 141-150.